XOMA Royalty (XOMA) Current Leases (2019 - 2026)
XOMA Royalty (XOMA) reported Current Leases of $2.4 million for Q1 2026, up 380.0% on a YoY basis from $500000.0 in Q1 2025, and down 4.0% sequentially from $2.5 million in Q4 2025.
XOMA Royalty (XOMA) Current Leases (2019 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 8 years of Current Leases data on file, last reported at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 380.0% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 380.0% YoY), and the FY2025 full-year result was $2.5 million, up 525.0% from the prior year.
- Current Leases eased to $2.4 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.5 million in Q4 2025 to a low of $17000.0 in Q2 2023.
- A 5-year average of $606812.5 and a median of $291000.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases tumbled 87.22% in 2023 and soared 2376.47% in 2024, its largest moves.
- Tracing XOMA's Current Leases over 5 years: stood at $34000.0 in 2022, then jumped by 194.12% to $100000.0 in 2023, then jumped by 300.0% to $400000.0 in 2024, then jumped by 525.0% to $2.5 million in 2025, then slipped by 4.0% to $2.4 million in 2026.
- Business Quant data shows XOMA's Current Leases at $2.4 million in Q1 2026, $2.5 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 17, 2025 | 1.88 Mn |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 421,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 133,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 195,000.00 |
| Sep 30, 2021 | 191,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Mar 31, 2021 | 183,000.00 |